Investigación que financiamos
Your generous support enables The ALS Association to fund millions of dollars in research every year, in locations across the globe. From individual projects to global collaborations, we provide funding to experts in a variety of scientific focus areas critical to advancing the search for treatments and cures for ALS.
Golden West Chapter Sponsored Research Initiatives
Sampling of Grants We Have Funded During the Past Year
| Grant ID | Project Title | Applicant | Award Start Date | Award End Date | Award Amount | Primary Organization | Program Name |
|---|---|---|---|---|---|---|---|
| 22-PDF-609 | An Integrated Genome-Based Approach to Individualised Treatment in ALS and FTD | Al Khleifat, Ahmad | 01/31/2022 | 09/30/2023 | 150000.00 | King's College London, Institute of Psychiatry | Milton Safenowitz Postdoctoral Fellowship Program |
| 23-SI-621 | 2022 Holloway Postdoc Fellowship (AFTD/ALS Association) | Anderson, Eric | 07/01/2022 | 06/30/2024 | 60000.00 | University of Pittsburgh | Strategic Initiative |
| 23-TC-631 | Harry J Hoenselaar ALS Clinic, Henry Ford Health Systems Detroit Proposal | Arcila Londono, Ximena | 12/01/2022 | 11/30/2026 | 400000.00 | Henry Ford Health System | Trial Capacity |
| 23-CSDA-618 | 2022 Clinician Scientist Development Award | Arnold, Frederick | 07/01/2022 | 06/30/2025 | 168000.00 | The Regents of the University of California (Irvine) | Clinician Scientist Development Award |
| 23-SI-622 | ALSUntangled | Bedlack, Richard | 07/01/2022 | 06/30/2025 | 66614.00 | Duke University | Strategic Initiative |
| 23-SGP-638 | Developing a blood test for the early detection of ALS | Dempster, Emma | 12/01/2022 | 11/30/2023 | 49987.00 | University of Exeter | Seed Grants Program |
| 22-DDC-613 | GLP Studies on Antisense Oligonucleotide Therapies | Elbaum, Daniel | 01/31/2022 | 01/30/2024 | 500000.00 | QurAlis Corporation | The Lawrence and Isabel Barnett Drug Development Award |
| 22-CTA-610 | RAPA-501 Hybrid TREG/Th2 Cell Therapy of ALS | Fowler, Daniel | 01/01/2022 | 12/31/2023 | 1000000.00 | Rapa Therapeutics, LLC | Clinical Trial Awards |
| 23-DDC-625 | TRPML1 small molecule agonists for the treatment of ALS | Gill, Martin | 10/01/2022 | 09/30/2024 | 450272.00 | Libra Therapeutics, Inc. | The Lawrence and Isabel Barnett Drug Development Award |
| 23-PDF-645 | Unraveling the Mechanism of Cryptic RNA Splicing Induced by TDP-43 Pathology | Guo, Caiwei | 12/01/2022 | 11/30/2024 | 150000.00 | Stanford University School of Medicine | Milton Safenowitz Postdoctoral Fellowship Program |
| 23-SGP-626 | Establishing an African ALS-research network to transform the ALS landscape | Heckmann, Jeannine | 10/01/2022 | 09/30/2023 | 50000.00 | University of Cape Town | Seed Grants Program |
| 23-TC-647 | Enhancement of Trial Capacity at Temple University ALS Center of Hope | Heiman-Patterson, Terry | 11/01/2022 | 10/31/2026 | 400000.00 | Temple University – Of The Commonwealth System of Higher Education | Trial Capacity |
| 23-SGP-627 | Uncovering the proteome of TDP-43 condensates in human neurons | Hornstein, Eran | 11/01/2022 | 11/01/2023 | 50000.00 | Weizmann Institute of Science | Seed Grants Program |
| 22-CTA-614 | Repurposing Enoxacin therapy for patients with ALS | Hornstein, Eran | 01/01/2022 | 12/31/2023 | 750000.00 | Weizmann Institute of Science | Clinical Trial Awards |
| 23-SGP-640 | Multisite Customizable Assistive Technology Intervention | Janes, William | 12/01/2022 | 11/30/2023 | 50000.00 | The Curators of the University of Missouri | Seed Grants Program |
| 23-SEA-620 | 2022 Sheila Essey Award for ALS Research | Kiernan, Matthew | 07/01/2022 | 06/30/2023 | 50000.00 | Neuroscience Research Australia (Prince of Wales Medical Research Institute) | Sheila Essey Award |
| 22-DDC-606 | Preclinical evaluation of bemcentinib as a novel therapeutic for ALS | Lee, Virginia | 01/15/2022 | 01/14/2024 | 500000.00 | Perelman School of Medicine, University of Pennsylvania | The Lawrence and Isabel Barnett Drug Development Award |
| 23-PDF-628 | Potentiation of a nuclear-import receptor to counteract aberrant TDP-43 assembly | Linsenmeier, Miriam | 11/01/2022 | 10/31/2024 | 133490.00 | Perelman School of Medicine, University of Pennsylvania | Milton Safenowitz Postdoctoral Fellowship Program |
| 22-PDF-605 | Pathomechanisms of ALS caused by SPTLC1 mutations | Pant, Devesh | 01/15/2022 | 01/14/2024 | 150000.00 | Emory University | Milton Safenowitz Postdoctoral Fellowship Program |
| 23-SGP-630 | Axl receptor as novel biomarker across the ALS and FTD spectrum | Peviani, Marco | 12/01/2022 | 11/30/2023 | 50000.00 | University of Pavia (Università degli Studi di Pavia) | Seed Grants Program |
| 23-PDF-623 | Applying the human disaggregase, HtrA1, to counter Amyotrophic Lateral Sclerosis | PURI, ANURADHIKA | 08/01/2022 | 07/31/2024 | 150000.00 | Washington University in St.Louis | Milton Safenowitz Postdoctoral Fellowship Program |
| 23-TC-644 | Safety & therapeutic potential of metformin for C9orf72 ALS | Ranum, Laura | 12/01/2022 | 11/30/2024 | 500000.00 | University of Florida | Clinical Trial Awards |
| 23-PDF-639 | [RESUBMISSION] Determining Changes in RNA and Protein Metabolism in ALS iMNs | Rhine, Kevin | 12/01/2022 | 11/30/2024 | 150000.00 | The Regents of the University of California, San Diego | Milton Safenowitz Postdoctoral Fellowship Program |
| 22-CTA-615 | Target NMJ to maintain motor functions in ALS | Robitaille, Richard | 01/30/2022 | 01/29/2025 | 996938.06 | University of Montreal (Université de Montréal) | Clinical Trial Awards |
| 22-DDC-608 | ASO mediated knockdown of CHMP7 as a novel therapeutic strategy for ALS/FTD | Rothstein, Jeffrey | 01/01/2022 | 12/31/2023 | 494444.00 | Johns Hopkins University School of Medicine | The Lawrence and Isabel Barnett Drug Development Award |
| 22-DDC-607 | Antagonism of RAGE/DIAPH1 and Therapies for Amyotrophic Lateral Sclerosis | Schmidt, Ann Marie | 01/01/2022 | 12/31/2023 | 500000.00 | New York University Grossman School of Medicine | The Lawrence and Isabel Barnett Drug Development Award |
| 23-SGP-641 | To investigate the relationship between exposure to tropical infections and ALS | Shahrizaila, Nortina | 12/01/2022 | 11/30/2023 | 49842.45 | University of Malaya | Seed Grants Program |
| 23-CRTF-619 | 2022 Clinical Research Training Scholarship | Shellikeri, Sanjana | 07/01/2022 | 06/30/2024 | 105000.00 | Perelman School of Medicine, University of Pennsylvania | Clinical Research Training Fellow |
| 22-CTA-611 | Acute adenosine receptor antagonism to promote breathing plasticity in ALS | Smith, Barbara | 01/01/2022 | 12/31/2024 | 880826.00 | University of Florida | Clinical Trial Awards |
| 23-SI-616 | Establishing causative roles for SARM1 coding & expression level variants in ALS | Sreedharan, Jemeen | 03/01/2022 | 08/31/2024 | 400000.00 | King's College London, Institute of Psychiatry | Strategic Initiative |
| 23-TC-632 | Increasing trial accessibility in underserved populations | Statland, Jeffrey | 12/01/2022 | 12/01/2026 | 400000.00 | University of Kansas Medical Center Research Institute, Inc. | Trial Capacity |
| 23-SI-617 | Maintain the SOD1 breeding colony in 2022 | Torvund-Jensen, Julie | 02/01/2022 | 01/31/2023 | 343410.00 | Taconic Biosciences, Inc. | Strategic Initiative |
| 23-SGP-635 | An Embedded Psychosocial Service for Patients with ALS and Informal Caregivers | Vranceanu, Ana Maria | 12/01/2022 | 11/30/2023 | 49995.00 | Massachusetts General Hospital (Mass General) | Seed Grants Program |
| 23-TC-633 | Saint Alphonsus ALS Trial Expansion | Whitesell, Jackie | 12/01/2022 | 12/01/2026 | 123844.00 | Saint Alphonsus Regional Medical Center Research Institute | Trial Capacity |